Skip to content

Clinical trials

Anemia, Refractory, with Excess of Blasts trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20061
20112
20141
20151
20192
20201
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated2
Unknown status2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC2
Apollo Therapeutics Ltd1
Celgene1
Leukemia Research Fund1
Medical Research Council1
Novartis Pharmaceuticals1
Riverside Haematology Group1
Skyline Diagnostics BV1
Stichting Hemato-Oncologie voor Volwassenen Nederland1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts16
Myelodysplastic Syndromes11
Leukemia, Myeloid, Acute9
Leukemia7
Congenital Abnormalities3
Leukemia, Erythroblastic, Acute3
Leukemia, Megakaryoblastic, Acute3
Leukemia, Monocytic, Acute3
Leukemia, Myelomonocytic, Acute3
Leukemia, Myelomonocytic, Chronic3

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.